Identification of genetic causes in children with unexplained epilepsy based on trio‐whole exome sequencing

Li Chengyan,Xue Chupeng,Wang You,Chen Yinhui,Huang Binglong,Ao Dang,Liu Ling,Tian Chuan
DOI: https://doi.org/10.1111/cge.14519
2024-03-13
Clinical Genetics
Abstract:Overall flow chart of genetic diagnosis for 135 individuals with unexplained epilepsy. Genotype and clinical phenotype analyses of 128 children were performed based on whole exome sequencing (WES), providing a reference for the provision of genetic counseling and the precise diagnosis and treatment of epilepsy. A total of 128 children with unexplained epilepsy were included in this study, and all their clinical data were analyzed. The children's treatments, epilepsy control, and neurodevelopmental levels were regularly followed up every 3 months. The genetic diagnostic yield of the 128 children with epilepsy is 50.8%, with an SNV diagnostic yield of 39.8% and a CNV diagnostic yield of 12.5%. Among the 128 children with epilepsy, 57.0% had onset of epilepsy in infancy, 25.8% have more than two clinical seizure forms, 62.5% require two or more anti‐epileptic drug treatments, and 72.7% of the children have varying degrees of psychomotor development retardation. There are significant differences between ages of onset, neurodevelopmental levels and the presence of drug resistance in the genetic diagnostic yield (all p
genetics & heredity
What problem does this paper attempt to address?